BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 19, 2013
View Archived Issues
New results reported in murine model of spinocerebellar ataxia
Read More
Isis Pharmaceuticals presents phase I data for ISIS-PTP-1BRx
Read More
Preclinical results and initiation of first-in-human trial of ATROSAB
Read More
Preclinical evaluation of miRNA inhibitor in severe PAH
Read More
PsychoGenics and Sunovion Pharmaceuticals expand CNS partnership
Read More
Genmab and ADC Therapeutics collaborate on antibody-drug conjugate
Read More
Genocea Biosciences prepares new vaccines for HSV-2 infection
Read More
First patient dosed in phase III study of Zubsolv for new indication
Read More
Amgen presents phase I results for AMG-181 in patients with Crohn's disease and ulcerative colitis
Read More
Fluvoxamine maleate enters Japanese phase III trial for pediatric OCD
Read More
DaVita and Myriad establish protein biomarker discovery collaboration
Read More
Additive therapy with ESKM leads to complete eradication of tumors in vivo
Read More
WHO issues interim guidance on bedaquiline for pulmonary multidrug-resistant TB
Read More
New EP2 receptor antagonists patented by Bayer
Read More
Civitas Therapeutics receives second Michael J. Fox Foundation grant for CVT-301
Read More
Beta Pharma presents novel HDAC6 inhibitors
Read More
Phenex Pharmaceuticals designs new RORgamma ligands
Read More
iCo Therapeutics completes enrollment in phase II iDEAL trial
Read More
Chinese researchers patent novel alpha1A-adrenoceptor antagonists
Read More
PhaseBio expands clinical development of Vasomera for cardiopulmonary diseases
Read More
Novel PARP-1 inhibitors presented by Chengdu Di'ao Pharmaceutical Group
Read More
MEI Pharma commences phase II trial of pracinostat and Vidaza in frontline MDS
Read More
ViroMed advances in phase II trial of VM-202-DPN
Read More
FDA obtains license from GVK Biosciences for GOSTAR database
Read More
Oxygen Biotherapeutics gives update on Oxycyte
Read More